{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:02:28Z","timestamp":1785852148521,"version":"3.56.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,4,1]]},"DOI":"10.1097\/01.qai.0000145352.04440.1e","type":"journal-article","created":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T04:00:44Z","timestamp":1109649644000},"page":"426-431","source":"Crossref","is-referenced-by-count":121,"title":["Alendronate, Vitamin D, and Calcium for the Treatment of Osteopenia\/Osteoporosis Associated With HIV Infection"],"prefix":"10.1097","volume":"38","author":[{"given":"Kristin","family":"Mondy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G","family":"Powderly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry A","family":"Claxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin H","family":"Yarasheski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Royal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S","family":"Stoneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Tebas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl","key":"R1-7-20210131","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","article-title":"Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy.","volume":"14","author":"Tebas","year":"2000","journal-title":"AIDS"},{"key":"R2-7-20210131","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/ajcn\/74.5.679","article-title":"Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women.","volume":"74","author":"McDermott","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"R3-7-20210131","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00002030-200104130-00005","article-title":"Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.","volume":"15","author":"Carr","year":"2001","journal-title":"AIDS"},{"key":"R4-7-20210131","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/00002030-200109280-00011","article-title":"Bone mineral loss through increased bone turnover in HIV-infected children treated with highly active antiretroviral therapy.","volume":"15","author":"Mora","year":"2001","journal-title":"AIDS"},{"key":"R5-7-20210131","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-137-1-200207020-00008","article-title":"High prevalence of osteonecrosis of the femoral head in HIV-infected adults.","volume":"137","author":"Miller","year":"2002","journal-title":"Ann Intern Med"},{"key":"R6-7-20210131","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/00002030-200109070-00019","article-title":"Reduced bone mineral density in HIV-positive individuals.","volume":"15","author":"Moore","year":"2001","journal-title":"AIDS"},{"key":"R7-7-20210131","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00002030-200104130-00022","article-title":"Osteopenia in HIV-infected patients: is it the disease or is it the treatment?","volume":"15","author":"Knobel","year":"2001","journal-title":"AIDS"},{"key":"R8-7-20210131","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00002030-200101260-00022","article-title":"Equivalent osteopenia in HIV-infected individuals studied before and during the era of highly active antiretroviral therapy.","volume":"15","author":"Lawal","year":"2001","journal-title":"AIDS"},{"key":"R9-7-20210131","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/jinf.2002.1109","article-title":"Osteopenia in HIV-infected women prior to highly active antiretroviral therapy.","volume":"46","author":"Teichmann","year":"2003","journal-title":"J Infect"},{"key":"R12-7-20210131","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/367569","article-title":"Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals.","volume":"36","author":"Mondy","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R13-7-20210131","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1086\/321870","article-title":"Alendronate treatment for osteoporosis in patients infected with human immunodeficiency virus.","volume":"33","author":"Guaraldi","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R14-7-20210131","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1210\/jcem.86.11.7988","article-title":"Alendronate treatment of established primary osteoporosis in men: results of a 2-year prospective study.","volume":"86","author":"Ringe","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-7-20210131","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJM200008313430902","article-title":"Alendronate for the treatment of osteoporosis in men.","volume":"343","author":"Orwoll","year":"2000","journal-title":"N Engl J Med"},{"key":"R16-7-20210131","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"R17-7-20210131","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00126334-200211010-00001","article-title":"Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.","volume":"31","author":"Schambelan","year":"2002","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00130478-200503000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:38:09Z","timestamp":1785850689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-200504010-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,1]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.qai.0000145352.04440.1e","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4,1]]}}}